FDA.reportPublic FDA data

2.4 ML Zepbound 12.5 MG/ML Pen Injector

RxCUI
2734626
RxNorm name
2.4 ML Zepbound 12.5 MG/ML Pen Injector
Display name
2.4 ML Zepbound 12.5 MG/ML Pen Injector
Full name
2.4 ML Zepbound 12.5 MG/ML Pen Injector
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:56

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZepboundTIRZEPATIDEEli Lilly and Company487cd7e7-434c-4925-99fa-aa80b1cc776b2026-04-22Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2734626

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
487cd7e7-434c-4925-99fa-aa80b1cc776bzepbound 7.5 MG per dose (30 MG in 2.4 ML) Pen Injector [PSN] · 2.4 ML tirzepatide 12.5 MG/ML Pen Injector [Zepbound] [SBD] · 2.4 ML Zepbound 12.5 MG/ML Pen Injector [SY] · Zepbound 30 MG per 2.4 ML Pen Injector [SY]438These highlights do not include all the information needed to use ZEPBOUND safely and effectively. See full prescribing information for ZEPBOUND. ZEPBOUND ® (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 202220260422